Moderna Stock Buy Hold or Sell Recommendation

MRNA -  USA Stock  

USD 142.28  6.02  4.42%

Given the investment horizon of 90 days and complete risk avoidance on your part, our recommendation regarding Moderna is 'Strong Sell'. Macroaxis provides Moderna buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Moderna positions. The advice algorithm takes into account all of Moderna's available fundamental, technical, and predictive indicators you will find on this site.
  
Refresh
The advice is provided from Moderna's buy-and-hold perspective. Additionally, see Moderna Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Moderna and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Moderna.

Execute Moderna Buy or Sell Advice

The Moderna recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Moderna. Macroaxis does not own or have any residual interests in Moderna or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Moderna's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell ModernaBuy Moderna
Strong Sell

Volatility

Very steadyDetails

Hype Condition

Low keyDetails

Current Valuation

UndervaluedDetails

Odds of Distress

Below AverageDetails

Economic Sensitivity

Hyperactively responds to market trendsDetails

Analyst Consensus

HoldDetails

Financial Strenth (F Score)

StrongDetails

Financial Leverage

InapplicableDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Moderna has a Mean Deviation of 4.05, Standard Deviation of 5.23 and Variance of 27.36
Macroaxis provides trade recommendations on Moderna to complement and cross-verify current analyst consensus on Moderna. Our advice engine determines the firm's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure Moderna is not overpriced, please verify all Moderna fundamentals, including its price to sales, cash per share, and the relationship between the number of shares shorted and ebitda . Given that Moderna has a number of shares shorted of 15.43 M, we recommend you to check Moderna market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your last-minute risk tolerance and investing horizon.

Moderna Trading Alerts and Improvement Suggestions

Moderna has very high historical volatility over the last 90 days
Moderna has a strong financial position based on the latest SEC filings
About 64.0% of the company shares are owned by institutional investors
Latest headline from www.investors.com: Vaccine Stocks Pfizer, BioNTech Score A Win Leading Pfizer To Make A Bullish Move - Investors Business Daily

Moderna current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Moderna analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Moderna analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Mean Price230.27
Target Median Price199.00
Target High Price506.00
Recommendation Mean2.50
Number Of Analyst Opinions15
Target Low Price80.00
Average Consensus Hold
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

Moderna Returns Distribution Density

The distribution of Moderna's historical returns is an attempt to chart the future uncertainty of Moderna's future price movements. The chart of the probability distribution of Moderna stock daily returns describes the distribution of returns around its average expected value. We use Moderna price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Moderna returns is essential to provide solid investment advice for Moderna stock.
Mean Return-0.06Value At Risk-7.33
Potential Upside8.59Standard Deviation5.23
 Return Density 
      Distribution 
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Moderna historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Moderna Cash Flow Accounts

201720182019202020212022 (projected)
Capital Expenditure(58.4 M)(105.77 M)(32 M)(68 M)(284 M)(291.47 M)
Depreciation Amortization and Accretion20.54 M24.86 M31 M93 M232 M250.32 M
Net Cash Flow or Change in Cash and Cash Equivalents86.05 M522.88 M(422 M)2.39 B4.22 B4.56 B
Issuance Purchase of Equity Shares212 K564.45 M51 M2.04 B(733 M)(752.29 M)
Net Cash Flow from Financing168 K1.23 B52 M2.03 B(873 M)(895.97 M)
Net Cash Flow from Investing417.36 M(373.09 M)(15 M)(1.67 B)(8.52 B)(8.75 B)
Net Cash Flow Investment Acquisitions and Disposals475.76 M(267.33 M)17 M(1.6 B)(8.24 B)(8.46 B)
Net Cash Flow from Operations(331.48 M)(330.87 M)(459 M)2.03 B13.62 B14.7 B
Share Based Compensation40.05 M72.56 M81 M93 M142 M119.89 M

Moderna Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Moderna or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Moderna stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Moderna stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over DOW
0.13
β
Beta against DOW2.12
σ
Overall volatility
5.11
Ir
Information ratio 0.0053

Moderna Volatility Alert

Moderna exhibits very low volatility with skewness of 0.65 and kurtosis of 0.63. However, we advise investors to further study Moderna technical indicators to make sure all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Moderna's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Moderna's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Moderna Implied Volatility

Moderna's implied volatility exposes the market's sentiment of Moderna stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Moderna's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Moderna stock will not fluctuate a lot when Moderna's options are near their expiration.

Moderna Fundamentals Vs Peers

Comparing Moderna's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Moderna's direct or indirect competition across all of the common fundamentals between Moderna and the related equities. This way, we can detect undervalued stocks with similar characteristics as Moderna or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Moderna's fundamental indicators could also be used in its relative valuation, which is a method of valuing Moderna by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Moderna to competition
FundamentalsModernaPeer Average
Return On Equity146.08 %(0.31) %
Return On Asset51.93 %(0.14) %
Profit Margin66.06 %(1.27) %
Operating Margin73.24 %(5.51) %
Current Valuation44.34 B16.62 B
Shares Outstanding397.76 M571.82 M
Shares Owned by Insiders9.43 %10.09 %
Shares Owned by Institutions63.93 %39.21 %
Number of Shares Shorted15.43 M4.71 M
Price to Earning4.82 X28.72 X
Price to Book3.88 X9.51 X
Price to Sales2.93 X11.42 X
Revenue18.47 B9.43 B
Gross Profit13.86 B27.38 B
EBITDA13.53 B3.9 B
Net Income12.2 B570.98 M
Cash and Equivalents10.73 B2.7 B
Cash per Share26.63 X5.01 X
Total Debt916 M5.32 B
Debt to Equity0.06 %48.70 %
Current Ratio1.76 X2.16 X
Book Value Per Share35.10 X1.93 K
Cash Flow from Operations13.62 B971.22 M
Short Ratio2.74 X4.00 X
Earnings Per Share28.29 X3.12 X
Price to Earnings To Growth(0.03) X4.89 X
Number of Employees2.7 K18.84 K
Beta1.54-0.15
Market Capitalization54.2 B19.03 B
Total Asset7.59 M29.47 B
Retained Earnings(1.54 B)9.33 B
Working Capital(1.59 M)1.48 B
Current Asset850 K9.34 B
   Exercise or conversion by Hoge Stephen of 10000 shares of Moderna subject to Rule 16b-3 [view details]

Moderna Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Moderna . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution322993.0
Daily Balance Of Power0.7718
Rate Of Daily Change1.04
Day Median Price139.99
Day Typical Price140.75
Market Facilitation Index0.0
Price Action Indicator5.3

About Moderna Buy or Sell Advice

When is the right time to buy or sell Moderna? Buying financial instruments such as Moderna Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Although Moderna investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2019 2020 2021 2022 (projected)
Current Assets1.13 B6.3 B16.07 B17.34 B
Total Assets1.59 B7.34 B24.67 B26.62 B

Use Investing Ideas to Build Portfolios

In addition to having Moderna in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Waste Management Thematic Idea Now

Waste Management
Waste Management Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Waste Management theme has 32 constituents.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Waste Management Theme or any other thematic opportunities.
View All  Next Launch Waste Management
Additionally, see Moderna Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Moderna information on this page should be used as a complementary analysis to other Moderna's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Complementary Tools for Moderna Stock analysis

When running Moderna price analysis, check to measure Moderna's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moderna is operating at the current time. Most of Moderna's value examination focuses on studying past and present price action to predict the probability of Moderna's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Moderna's price. Additionally, you may evaluate how the addition of Moderna to your portfolios can decrease your overall portfolio volatility.
CEO Directory
Screen CEOs from public companies around the world
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Is Moderna's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Moderna. If investors know Moderna will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Moderna listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Moderna is measured differently than its book value, which is the value of Moderna that is recorded on the company's balance sheet. Investors also form their own opinion of Moderna's value that differs from its market value or its book value, called intrinsic value, which is Moderna's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Moderna's market value can be influenced by many factors that don't directly affect Moderna's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Moderna's value and its price as these two are different measures arrived at by different means. Investors typically determine Moderna value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Moderna's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.